A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Mckesson Corp stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 21,305 shares of MCK stock, worth $13.2 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
21,305
Previous 40,136 46.92%
Holding current value
$13.2 Million
Previous $23.4 Million 55.06%
% of portfolio
0.04%
Previous 0.09%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$479.06 - $630.38 $9.02 Million - $11.9 Million
-18,831 Reduced 46.92%
21,305 $10.5 Million
Q2 2024

Jul 26, 2024

BUY
$518.81 - $607.81 $9.08 Million - $10.6 Million
17,497 Added 77.29%
40,136 $23.4 Million
Q1 2024

Apr 24, 2024

SELL
$473.42 - $539.26 $1.41 Million - $1.6 Million
-2,974 Reduced 11.61%
22,639 $12.2 Million
Q4 2023

Feb 09, 2024

BUY
$437.42 - $470.64 $1.68 Million - $1.81 Million
3,844 Added 17.66%
25,613 $11.9 Million
Q3 2023

Oct 24, 2023

BUY
$402.4 - $446.42 $2.59 Million - $2.87 Million
6,438 Added 41.99%
21,769 $9.47 Million
Q2 2023

Jul 13, 2023

SELL
$354.01 - $427.31 $8.45 Million - $10.2 Million
-23,881 Reduced 60.9%
15,331 $6.55 Million
Q1 2023

May 11, 2023

BUY
$335.35 - $386.06 $989,617 - $1.14 Million
2,951 Added 8.14%
39,212 $14 Million
Q4 2022

Feb 08, 2023

BUY
$346.68 - $397.58 $3.5 Million - $4.01 Million
10,093 Added 38.57%
36,261 $13.6 Million
Q3 2022

Oct 17, 2022

BUY
$321.25 - $373.84 $2.84 Million - $3.3 Million
8,839 Added 51.01%
26,168 $8.89 Million
Q2 2022

Jul 13, 2022

BUY
$300.57 - $336.42 $453,259 - $507,321
1,508 Added 9.53%
17,329 $5.65 Million
Q1 2022

May 12, 2022

SELL
$244.61 - $310.48 $27,151 - $34,463
-111 Reduced 0.7%
15,821 $4.84 Million
Q4 2021

Feb 03, 2022

BUY
$198.21 - $248.9 $197,417 - $247,904
996 Added 6.67%
15,932 $3.96 Million
Q3 2021

Nov 02, 2021

SELL
$188.42 - $208.66 $599,364 - $663,747
-3,181 Reduced 17.56%
14,936 $2.98 Million
Q2 2021

Aug 10, 2021

BUY
$184.89 - $202.68 $128,498 - $140,862
695 Added 3.99%
18,117 $3.46 Million
Q1 2021

May 07, 2021

BUY
$169.52 - $196.53 $249,024 - $288,702
1,469 Added 9.21%
17,422 $3.4 Million
Q4 2020

Feb 04, 2021

BUY
$143.79 - $183.66 $165,070 - $210,841
1,148 Added 7.75%
15,953 $2.77 Million
Q3 2020

Oct 29, 2020

BUY
$140.89 - $159.9 $190,765 - $216,504
1,354 Added 10.07%
14,805 $2.2 Million
Q2 2020

Jul 27, 2020

SELL
$125.49 - $164.68 $106,541 - $139,813
-849 Reduced 5.94%
13,451 $2.06 Million
Q1 2020

May 08, 2020

SELL
$115.75 - $170.96 $3.9 Million - $5.76 Million
-33,705 Reduced 70.21%
14,300 $1.93 Million
Q4 2019

Feb 04, 2020

BUY
$130.23 - $153.27 $256,813 - $302,248
1,972 Added 4.28%
48,005 $6.64 Million
Q3 2019

Nov 06, 2019

BUY
$134.24 - $148.53 $295,328 - $326,766
2,200 Added 5.02%
46,033 $6.29 Million
Q3 2019

Oct 28, 2019

BUY
$134.24 - $148.53 $805 - $891
6 Added 0.01%
43,833 $5.99 Million
Q2 2019

Aug 15, 2019

BUY
$112.47 - $134.93 $245,072 - $294,012
2,179 Added 5.23%
43,827 $0
Q1 2019

May 08, 2019

SELL
$111.86 - $136.3 $473,279 - $576,685
-4,231 Reduced 9.22%
41,648 $0
Q4 2018

Feb 05, 2019

SELL
$108.23 - $136.84 $133,231 - $168,450
-1,231 Reduced 2.61%
45,879 $5.07 Million
Q3 2018

Nov 02, 2018

SELL
$123.14 - $138.52 $6,157 - $6,926
-50 Reduced 0.11%
47,110 $0
Q2 2018

Aug 10, 2018

BUY
$133.4 - $158.13 $3 Million - $3.56 Million
22,510 Added 91.32%
47,160 $0
Q1 2018

May 09, 2018

BUY
$138.75 - $176.72 $467,310 - $595,192
3,368 Added 15.83%
24,650 $0
Q4 2017

Feb 22, 2018

SELL
$135.02 - $162.6 $14,177 - $17,073
-105 Reduced 0.49%
21,282 $0
Q3 2017

Nov 07, 2017

SELL
$146.0 - $161.87 $815,556 - $904,205
-5,586 Reduced 20.71%
21,387 $3.29 Million
Q2 2017

Aug 08, 2017

BUY
N/A
26,973
26,973 $4.44 Million

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $89.3B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.